Home | Drugs Approvals and Trials

Drugs Approvals and Trials

MDA Collaborates with AVI BioPharma on First Phase 2 Placebo-Controlled Clinical Trial of Exon-51 Skipping Drug as Potential Therapy for Duchenne Muscular Dystrophy

Columbus, OH - More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grassroots special events, has culminated in MDA providing financial assistance for the start of the first phase 2 placebo-controlled, multiple-dose efficacy, safety, tolerability and pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, as a potential therapy for Duchenne muscular dystrophy (DMD).
Full story

New Study is the First North American Clinical Trial to Test Adult Mesenchymal Stem Cell Transplantation as a New Therapy for MS

A team of researchers at three landmark Cleveland institutions have come together to launch a new clinical trial of an experimental treatment for multiple sclerosis (MS). ...
Full story

Research set to improve processes for NHS drug approvals

Researchers from the University of Sheffield and the University of Liverpool have identified ways in which the process of approving drugs for use on the NHS can be improved....
Full story

FDA approves Adcetris to treat two types of lymphoma

The U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL)....
Full story

U-M participates in study to reduce debilitating effects of stroke in diabetic patients

50+ center clinical trial is being coordinated through U-M based Neurological Emergencies Treatment Trials (NETT) network...
Full story

FDA approves Zelboraf and companion diagnostic test for late-stage skin cancer

Second melanoma drug approved this year that improves overall survival ...
Full story

FDA approves the first specific treatment for scorpion stings

The U.S. Food and Drug Administration today approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States....
Full story

Hepatitis C study seeks more volunteers

La Trobe University is calling for Australians with Hepatitis C to participate in the national Charting Health Impacts study in a bid to improve treatment and services....
Full story

Trials move closer to treat Duchenne Muscular Dystrophy

Findings from clinical trials for Duchenne Muscular Dystrophy, using a compound designed in The University of Western Australia and Australian Neuro-muscular Research Institute laboratories of Professors Steve Wilton and Sue Fletcher have been published today in the prestigious medical research journal The Lancet. ...
Full story

Study investigates drug-free relief for tension headaches

As Australia marks its first National Pain Week (24-30 July), RMIT University researchers have begun recruiting volunteers for a new study investigating the use of acupuncture and counselling as a treatment for tension headaches....
Full story
back 1 2 3 4 5 6 7 8 9 10 next last total: 395 | displaying: 81 - 90
Log in